510(k) Report

510(k) · Cleared

Cleared

Sysmex CS-2100i

K162688510(k) TraditionalCleared Dec 26, 201690-day reviewClass II21 CFR 864.5425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Healthcare Diagnostics Products GmbH · JPA System, Multipurpose For In Vitro Coagulation Studies

Cleared on Dec 26, 2016 as substantially equivalent to K011235 (Dade Behring, Inc., 2001) after a 90-day review. Its family tree reaches back 1 generation to 2001.

Decided
Dec 26, 2016
Review
90 days
Class
Class II
Product code
JPA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K011235 (2001). No later device cites it as a predicate yet.

K011235 · Sysmex Automated Coagulation Analyzer / Model # CA-1500 · Dade Behring, Inc. · 20012000200520102015
  1. Root · 1 generation backK011235 Sysmex Automated Coagulation Analyzer / Model # CA-1500Dade Behring, Inc. · 2001
  2. This deviceK162688 Sysmex CS-2100iSiemens Healthcare Diagnostics Products GmbH · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K011235Sysmex Automated Coagulation Analyzer / Model # CA-1500Dade Behring, Inc.2001—
0 (this device)K162688Sysmex CS-2100iSiemens Healthcare Diagnostics Products GmbH2016—
FIG. 1 — Lineage of K162688, 2001–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JPA device

  1. #1 K243858 TEG 6s Hemostasis System Citrated: K, KH, RT…score 12.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011235Sysmex Automated Coagulation Analyzer / Model # CA-1500
Summary page 5
…Panel Hematology 3 Predicate Device Name of Device: Sysmex® Automated Blood Coagulation Analyzer CA-1500 (K011235) Common or Usual Name: Sysmex® CA-1500 Classification Name: Multipurpose system for in vitro coagulation…
Dade Behring, Inc.2001—

Also cleared against K011235: 7 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 7 other devices also cite its predicate K011235.

How does its category compare?

All JPA devices

JPA System, Multipurpose For In Vitro Coagulation Studies: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · JPA

3in 2025

2007: 12008: 22009: 62010: 12011: 12013: 12015: 22016: 62017: 42018: 12019: 32021: 12022: 12023: 32024: 12025: 32026 (partial year): 1
2007high 6 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPA

30in 2025

2009: 91 days median2016: 114 days median2017: 117 days median2019: 175 days median2023: 506 days median2025: 30 days median
2007high 506 (2023) · low 30 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPA

1in 2020

2007: 12010: 62011: 42012: 12016: 32020: 12026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPA

11in 2025

2007: 1,7442008: 9182009: 1,3632010: 7272011: 1612012: 522013: 432014: 482015: 452016: 62017: 152018: 392019: 272020: 182021: 72022: 92023: 112024: 82025: 11
2007high 1,744 (2007) · low 6 (2016)2025

MAUDE reports naming product code JPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—11,744
20082—0918
200969101,363
20101—6727
20111—4161
20120—152
20131—043
20140—048
20152—045
2016611436
20174117015
20181—039
20193175027
20200—118
20211—07
20221—09
20233506011
20241—08
2025330011
20261—1—

What is it indicated for?

For Sysmex® CS-2100i: The Sysmex CS-2100i is a fully automated blood coagulation analyzer intended for in vitro diagnostic use using plasma collected from venous blood samples in 3.2% sodium citrate tubes to analyze clotting, chromogenic and immunoassay methods in the clinical laboratory. For determination of: • Prothrombin Time (PT) seconds and PT INR with Dade® Innovin® • Activated Partial Thromboplastin Time (APTT) with Dade® Actin® FSL • Fibrinogen…

Read the full statement (242 words)

For Sysmex® CS-2100i:

The Sysmex CS-2100i is a fully automated blood coagulation analyzer intended for in vitro diagnostic use using plasma collected from venous blood samples in 3.2% sodium citrate tubes to analyze clotting, chromogenic and immunoassay methods in the clinical laboratory.

For determination of:

• Prothrombin Time (PT) seconds and PT INR with Dade® Innovin®

• Activated Partial Thromboplastin Time (APTT) with Dade® Actin® FSL

• Fibrinogen (Fbg) with Dade® Thrombin Reagent

• Coagulation Factor V with Dade® Innovin®

• Coagulation Factor VII with Dade® Innovin®

• Protein C with Protein C Reagent

• Antithrombin (AT) with INNOVANCE® Antithrombin

• Protein C with Berichrom® Protein C

• D-dimer with INNOVANCE® D-Dimer

The performance of this device has not been established in neonate and pediatric patient populations.

For Coagulation Factor V Deficient Plasma:

Intended Use

In vitro diagnostic reagent for the determination of the activity of coagulation factor V in human plasma.

For Coagulation Factor VII Deficient Plasma:

Intended Use

In vitro diagnostic reagents for the determination of the activity of coagulation factor II (prothrombin), coagulation factor VII and coagulation factor X in human plasma by coagulometric methods.

For Protein C Reagent:

Intended Use

Protein C Reagent is a coagulation test for the quantitative determination of protein C activity in human plasma.

For Berichrom® Protein C:

Intended Use

For the quantitative determination of functionally active protein C using a chromogenic substrate as an aid in the diagnosis of inherited and acquired deficiencies.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K162688: Sysmex CS-2100i.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162688

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026